Atea Pharmaceuticals Inc

AVIR

—

Build a strategy around AVIR

Atea Pharmaceuticals Inc AI Insights

Informational only. Not investment advice.

Analyzing financial metrics...

This may take a few seconds

Professional, Scientific, and Technical Services → Professional, Scientific, and Technical Services

Metric	Value	Industry Percentile
Market Cap	$339.31M	—
Enterprise Value	$260.63M	—
P/E Ratio	0.00	—
Total Revenue - TTM	$0	—
Earnings Per Share (diluted) - TTM	$0.00	—
Operating Margin - TTM	0%	—
Net Margin - TTM	0%	—
Free Cash Flow - TTM	$0	—
Return on Common Equity - TTM	0%	—
Beta 5Y (Monthly)	unknown	—

No dividends

No stock splits

Filing Date	Report Date	Report Type	Filing Link
05/12/26	03/31/26	10-Q	0001193125-26-219678
03/05/26	12/31/25	10-K	0001193125-26-094159
11/12/25	09/30/25	10-Q	0001193125-25-277815
08/07/25	06/30/25	10-Q	0000950170-25-105123
05/12/25	03/31/25	10-Q	0000950170-25-069367
03/06/25	12/31/24	Unknown	0000950170-25-034808
11/07/24	09/30/24	10-Q	0000950170-24-123447
08/07/24	06/30/24	10-Q	0000950170-24-092914
05/14/24	03/31/24	10-Q	0000950170-24-059699
02/28/24	12/31/23	10-K	0000950170-24-022226
11/08/23	09/30/23	10-Q	0000950170-23-061213
08/08/23	06/30/23	10-Q	0000950170-23-039920
05/08/23	03/31/23	10-Q	0000950170-23-018869
02/28/23	12/31/22	10-K	0000950170-23-005186
11/07/22	09/30/22	10-Q	0000950170-22-022699
08/08/22	06/30/22	10-Q	0000950170-22-015570
05/10/22	03/31/22	10-Q	0000950170-22-008732
02/28/22	12/31/21	10-K	0001564590-22-007672
11/12/21	09/30/21	10-Q	0001564590-21-056513
08/12/21	06/30/21	10-Q	0001564590-21-044060
05/13/21	03/31/21	10-Q	0001564590-21-027644
03/30/21	12/31/20	10-K	0001564590-21-016724
12/10/20	09/30/20	10-Q	0001564590-20-056724
10/30/20	06/30/20	424B4	0001193125-20-282645
05/13/21	03/31/20	10-Q	0001564590-21-027644
10/30/20	12/31/19	424B4	0001193125-20-282645
12/10/20	09/30/19	10-Q	0001564590-20-056724